par Bentin, Jacques 
;Fernandez Lopez, Maria Jose ;Dragan, Eliza;Eloundou, P.;Peretz, Anne
Référence Revue médicale de Bruxelles, 35, 4, page (207-214)
Publication Publié, 2014-09
;Fernandez Lopez, Maria Jose ;Dragan, Eliza;Eloundou, P.;Peretz, Anne Référence Revue médicale de Bruxelles, 35, 4, page (207-214)
Publication Publié, 2014-09
Article révisé par les pairs
| Résumé : | In recent decades, gout became the most common inflammatory arthritis and one in which pathogenesis and risk factors are best understood. One of the treatment objectives in current guidelines is " cure ". However, audits show that minority of patients with gout receive adequate advice and treatment. Doctors often focus on managing acute attacks rather than viewing gout as a chronic progressive crystal deposition disease. Accordingly, uratelowering treatment is underprescribed and often underdosed. The recent introduction of a panel of new treatments of gout and a better understanding of epidemiologic factors (such as the fructose) may improve management of this easily diagnosed and curable form of potentially severe arthritis, worsening probably the cardiovascular prognostic. |
